Aristippos Gennadios, Group President Pharma & Consumer at Catalent, Inc. (CTLT), sold 349 shares at $58.70 ($20K) on 2024-07-29, disclosed to the SEC on 2024-07-30.
Seasonal sale ($20k) by Group President Pharma & Consumer — this insider has traded CTLT in July in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CTLT | SELL | 2023-08-03 | $13K | — | Filing → |
| CTLT | SELL | 2022-08-26 | $339K | — | Filing → |
| CTLT | SELL | 2022-07-28 | $43K | — | Filing → |